Pharmathene(PIP)

0.0000 0.0000 0.0%

今开:0.0昨收:0.0
最高:0.0 最低:0.0
涨停价:0.0跌停价:0.0
总市值:4.85147E7

Pharmathene的热门讨论

Pharmathene(PIP)2019-08-15 01:05

$Pharmathene(PIP)$ 8-K - Current report Filed: 2019-08-13 AccNo: 0001564590-19-031811 Size: 395 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接查看全文

Pharmathene(PIP)2019-08-17 09:55

$Pharmathene(PIP)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2019-08-14 AccNo: 0001193125-19-221188 Size: 52 KB 网页链接查看全文

Pharmathene(PIP)2019-08-15 01:05

$Pharmathene(PIP)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-13 AccNo: 0001564590-19-031795 Size: 5 MB 网页链接查看全文

Pharmathene(PIP)2019-08-11 03:00

$Pharmathene(PIP)$ PRE 14A - Other preliminary proxy statements Filed: 2019-08-09 AccNo: 0001193125-19-218069 Size: 921 KB 网页链接查看全文

Pharmathene(PIP)2019-10-02 04:50

$Pharmathene(PIP)$ 8-K - Current report Filed: 2019-10-01 AccNo: 0001193125-19-259847 Size: 38 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 5.07: Submission o...查看全文

Pharmathene(PIP)2019-08-23 14:35

$Pharmathene(PIP)$ DEF 14A - Other definitive proxy statements Filed: 2019-08-22 AccNo: 0001193125-19-226618 Size: 964 KB 网页链接查看全文

Pharmathene(PIP)2019-08-22 15:10

$Pharmathene(PIP)$ 8-K - Current report Filed: 2019-08-21 AccNo: 0001193125-19-225595 Size: 34 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接查看全文

Pharmathene(PIP)2019-08-21 03:40

$Pharmathene(PIP)$ PRER14A - Preliminary Proxy Soliciting materials Filed: 2019-08-19 AccNo: 0001193125-19-224357 Size: 965 KB 网页链接查看全文

胡千杨2018-08-29 22:39

$ATA(ATAI)$ 这种股票太好抓了,套路非常一致。记得去年有个叫$PHARMATHENE INC(PIP)$ 的,也是这调调。查看全文

Pharmathene(PIP)2019-07-16 02:45

$Pharmathene(PIP)$ 8-K - Current report Filed: 2019-07-15 AccNo: 0001193125-19-193586 Size: 39 KBItem 2.01: Completion of Acquisition or Disposition of AssetsItem 3.02: Unregistered Sales of Equity SecuritiesItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements a...查看全文

1 2 3 4 5

Pharmathene的最新讨论

1 2

Pharmathene的公告

$Pharmathene(PIP)$ 8-K - Current report Filed: 2019-10-01 AccNo: 0001193125-19-259847 Size: 38 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 5.07: Submission o...

$Pharmathene(PIP)$ DEF 14A - Other definitive proxy statements Filed: 2019-08-22 AccNo: 0001193125-19-226618 Size: 964 KB 网页链接

$Pharmathene(PIP)$ 8-K - Current report Filed: 2019-08-21 AccNo: 0001193125-19-225595 Size: 34 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接

$Pharmathene(PIP)$ PRER14A - Preliminary Proxy Soliciting materials Filed: 2019-08-19 AccNo: 0001193125-19-224357 Size: 965 KB 网页链接

$Pharmathene(PIP)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2019-08-14 AccNo: 0001193125-19-221188 Size: 52 KB 网页链接

$Pharmathene(PIP)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-13 AccNo: 0001564590-19-031795 Size: 5 MB 网页链接

$Pharmathene(PIP)$ 8-K - Current report Filed: 2019-08-13 AccNo: 0001564590-19-031811 Size: 395 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接

$Pharmathene(PIP)$ PRE 14A - Other preliminary proxy statements Filed: 2019-08-09 AccNo: 0001193125-19-218069 Size: 921 KB 网页链接

$Pharmathene(PIP)$ 8-K - Current report Filed: 2019-07-15 AccNo: 0001193125-19-193586 Size: 39 KBItem 2.01: Completion of Acquisition or Disposition of AssetsItem 3.02: Unregistered Sales of Equity SecuritiesItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements a...

$Pharmathene(PIP)$ 8-K - Current report Filed: 2019-07-09 AccNo: 0001193125-19-190926 Size: 7 MBItem 1.01: Entry into a Material Definitive AgreementItem 3.02: Unregistered Sales of Equity SecuritiesItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibi...

1 2 3 4 5 6 7 8 9 10 11 12 13 14